The New England Journal of Medicine
Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer
Randomised trial in 724 peopleInterventions
Placebo-controlled, registered NCT00863655
The paper
Harvard University; The University of Texas MD Anderson Cancer Center
The New England Journal of Medicine, 7 Dec 2011

